Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.56 USD | -3.00% |
|
-1.19% | -20.63% |
Financials (USD)
Sales 2024 * | 1.88M | Sales 2025 * | 9.39M | Capitalization | 2.76B |
---|---|---|---|---|---|
Net income 2024 * | -225M | Net income 2025 * | -269M | EV / Sales 2024 * | 1,084 x |
Net cash position 2024 * | 727M | Net cash position 2025 * | 650M | EV / Sales 2025 * | 225 x |
P/E ratio 2024 * |
-12.6
x | P/E ratio 2025 * |
-11.4
x | Employees | 255 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.44% |
Latest transcript on Xenon Pharmaceuticals Inc.
1 day | -3.00% | ||
1 week | -1.19% | ||
Current month | -6.23% | ||
1 month | -3.97% | ||
3 months | -11.84% | ||
6 months | -18.59% | ||
Current year | -20.63% |
![Extreme 35.95](/images/extremecours_fleche.png)
![Extreme 35.53](/images/extremecours_fleche.png)
![Extreme 35.53](/images/extremecours_fleche.png)
![Extreme 27.985](/images/extremecours_fleche.png)
![Extreme 14.6535](/images/extremecours_fleche.png)
![Extreme 7](/images/extremecours_fleche.png)
![Extreme 2.1](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Ian Mortimer
CEO | Chief Executive Officer | 48 | 13-10-20 |
Sherry Aulin
DFI | Director of Finance/CFO | 41 | 10-12-31 |
Chief Tech/Sci/R&D Officer | 53 | 21-08-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Clarence Machado
BRD | Director/Board Member | 60 | 20-11-04 |
Justin Gover
BRD | Director/Board Member | 53 | 23-08-07 |
Gary Patou
BRD | Director/Board Member | 65 | 03-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 15 M€ | -5.72% | ||
0.22% | 0 M€ | 0.00% | - | |
0.22% | 0 M€ | 0.00% | - | |
0.20% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 36.56 | -3.00% | 267,905 |
24-07-01 | 37.69 | -3.33% | 767,551 |
24-06-28 | 38.99 | +4.22% | 498,273 |
24-06-27 | 37.41 | +2.30% | 669,310 |
24-06-26 | 36.57 | -1.16% | 423,780 |
Delayed Quote Nasdaq, July 02, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.63% | 2.76B | |
+16.44% | 122B | |
+18.94% | 113B | |
+18.57% | 26.22B | |
-25.37% | 19.01B | |
-19.77% | 15.71B | |
-20.20% | 15.22B | |
-47.37% | 14.72B | |
+59.91% | 14.58B | |
+4.35% | 13.84B |
- Stock Market
- Equities
- XENE Stock